3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
32
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
4
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Infertility
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasms by Site
1
Hypogonadism
1
Hot Flashes
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Anovulation
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Metformin
9
Inositol
5
Letrozole
4
Surveys and Questionnaires
3
Clomiphene
3
semaglutide
1
mirabegron
1
maltodextrin
1
dapagliflozin
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sex Characteristics
1
Positron-Emission Tomography
1
Pioglitazone
1
Pharmaceutical Preparations
1
Liraglutide
1
Hydroquinones
1
Diet, Mediterranean
1
Diet, Ketogenic
1
Contraceptives, Oral
1
Calibration
1
Ascorbic Acid
1
Acupuncture Therapy
1
5-methyltetrahydrofolate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Tamoxifen
×
90 days
×
Clear all
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled